Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on Equity

Intelligent Bio Solutions (INBS) EBIT Margin (2019 - 2025)

Intelligent Bio Solutions has reported EBIT Margin over the past 6 years, most recently at 358.55% for Q1 2024.

  • For Q1 2024, EBIT Margin rose 107308.0% year-over-year to 358.55%; the TTM value through Mar 2024 reached 359.87%, up 14883.0%, while the annual FY2023 figure was 1002.11%, 46914.0% down from the prior year.
  • EBIT Margin for Q1 2024 was 358.55% at Intelligent Bio Solutions, down from 260.63% in the prior quarter.
  • Over five years, EBIT Margin peaked at 174.89% in Q2 2022 and troughed at 9158.69% in Q1 2021.
  • A 5-year average of 1265.42% and a median of 603.65% in 2022 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: surged 21319908bps in 2020 and later tumbled -727846bps in 2021.
  • Year by year, EBIT Margin stood at 324.1% in 2020, then tumbled by -502bps to 1949.84% in 2021, then skyrocketed by 69bps to 597.45% in 2022, then soared by 56bps to 260.63% in 2023, then tumbled by -38bps to 358.55% in 2024.
  • Business Quant data shows EBIT Margin for INBS at 358.55% in Q1 2024, 260.63% in Q4 2023, and 317.35% in Q3 2023.